Atlas Trials

Efficacy and Safety of TILs in Treatment of Patients With Advanced or Metastatic Refractory Gynecological Cancer

Clinical trial NCT05152797 · NOT_YET_RECRUITING

Trial details

NCT number
NCT05152797
Sponsor
Women's Hospital School Of Medicine Zhejiang University
Status
NOT_YET_RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Tumor Infiltrating Lymphocytes
Start date
2022-01-01
Primary completion
2024-01-01
Enrollment
91

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.